Urology
Volume 57, Issue 4, Supplement 1 , Pages 86-89, April 2001

Other novel agents: Rationale and current status as chemopreventive agents

  • Anthony W Tolcher

      Affiliations

    • Institute for Drug Development, Cancer Therapy and Research Center, San Antonio, Texas, USA (AWT)
    • Corresponding Author InformationReprint requests: Anthony W. Tolcher, MD, Institute for Drug Development, Cancer Therapy and Research Center, 8122 Datapoint Drive, Suite 250, San Antonio, TX 78229
    • ,
  • Ann Kennedy

      Affiliations

    • University of Pennsylvania Medical Center, Philadelphia, Pennsylvania, USA (AK)
    • ,
  • Robert J Padley

      Affiliations

    • Abbott Laboratories, Abbott Park, Illinois, USA (RJP)
    • ,
  • Noreen Majeed

      Affiliations

    • McGill University, Montreal, Quebec, Canada (NM, MP)
    • ,
  • Michael Pollak

      Affiliations

    • McGill University, Montreal, Quebec, Canada (NM, MP)
    • ,
  • Philip W Kantoff

      Affiliations

    • Dana-Farber Cancer Institute, Boston, Massachusetts, USA (PWK)

To access this article, please choose from the options below

Login to an existing account or Register a new account.

  • Purchase this article for 31.50 USD (You must login/register to purchase this article)

    Online access for 24 hours. The PDF version can be downloaded as your permanent record.

  • Subscribe to this title

    Get unlimited online access to this article and all other articles in this title 24/7 for one year.

  • Claim access now

    For current subscribers with Society Membership or Account Number.

  • Visit SciVerse ScienceDirect to see if you have access via your institution.

PII: S0090-4295(00)00948-1

Urology
Volume 57, Issue 4, Supplement 1 , Pages 86-89, April 2001

Article Tools